As of Wednesday close, Inspire Medical Systems Inc.’s (NYSE:INSP) stock was up $10.02, moving up 4.40 percent to $237.55. The average number of shares traded per day over the past five days has been 612,940 shares. 4 times new highs have been achieved over the past 5 days, with a $26.27 gain in that time frame. In the last twenty days, the average volume was 630,040, while in the previous 50 days, it was 550,130.
Since last month, INSP stock retreated -18.35%. Shares of the company fell to $209.41 on 08/17/23, the lowest level in the past month. A 52-week high of $330.00 was reached on 07/14/23 after having rallying from a 52-week low of $159.62. Since the beginning of this year, INSP’s stock price has dropped by -5.69% or -$14.33, and marked a new high 24 times. However, the stock has declined by -28.02% since its 52-week high.
INSP stock investors should be aware that Inspire Medical Systems Inc. (INSP) stock had its last reported insider trading activity 31 days ago on Jul 31. Griffin Jerry C, the Director of the company, disposed of 529 shares for $290.47 on Jul 31. It resulted in a $153,659 divestment by the insider. Griffin Jerry C sold 529 shares at an average price of $304.99 on Jul 24. The insider now owns 8,381 shares following the transaction. On Jul 17, Director Griffin Jerry C sold 529 shares at $326.84 apiece. The transaction was valued at $172,898.
Valuation Metrics
The stock’s beta is 1.40. Besides these, the trailing price-to-sales (P/S) ratio of 13.23, the price-to-book (PB) ratio of 13.12, and the price-to-cash flow ratio of 368.27 may also be considered.
Financial Health
In the three months ended June 29, Inspire Medical Systems Inc.’s quick ratio stood at 8.10, while its current ratio was 8.40, showing that the company is able to pay off its debt. On the profitability front, the trailing twelve-month gross margin is 83.60% percent. In the year ended June 29, EBITDA margin amounted to -10.96%, whereas operating margins totaled -10.20%. Based on annual data, INSP earned $341.74 million in gross profit and brought in $407.86 million in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was -9.70%. Return on equity (ROE) for the past 12 months was -8.20%.
According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. INSP’s revenue rose 39.51% to $127.9 million during the quarter, while net income inched up to $151.09 million. While analysts expected Inspire Medical Systems Inc. to report -$0.57 quarterly earnings, the actual figure was -$0.41 per share, beating the consensus estimate by 28.10%. During the quarter, the company generated -$15.94 million in EBITDA. The liabilities of Inspire Medical Systems Inc. were 88.89 million at the end of its most recent quarter ended June 29, and its total debt was $23.37 million. The value of shareholders’ equity is $29.34 million.
Technical Picture
This quick technical analysis looks at Inspire Medical Systems Inc.’s (INSP) price momentum. With a historical volatility rate of 30.63%, the RSI 9-day stood at 53.30% on 30 August.
With respect to its five-day moving average, the current Inspire Medical Systems Inc. price is up by +12.43% percent or $26.27. At present, INSP shares trade -14.49% below its 20-day simple moving average and +1.51% percent above its 100-day simple moving average. However, the stock is currently trading approximately -24.14% below its SMA50 and +9.23% above its SMA200.
Stochastic coefficient K was 40.32% and Stochastic coefficient D was 25.78%, while ATR was 9.98. Given the Stochastic reading of 61.36% for the 14-day period, the RSI (14) reading has been calculated as 44.90%. As of today, the MACD Oscillator reading stands at 8.29, while the 14-day reading stands at 2.22.
Analyst Ratings
Robert W. Baird launched its rating on Inspire Medical Systems Inc. (NYSE: INSP) to an Outperform in a note to investors on July 19, 2023. Inspire Medical Systems Inc. (INSP) has been rated Buy by analysts. According to 0 brokerage firms, INSP is a sell, and 3 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 1 analyst rate Inspire Medical Systems Inc. stock as buy, with 11 recommending it as overweight.
With a median target price of $352.50, the current consensus forecast for the stock is $330.00 – $405.00. Based on these forecasts, analysts predict Inspire Medical Systems Inc. (INSP) will achieve an average price target of $356.83.
